Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

1 Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study British Medical Journal, April 23, 2013

2 A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the cancer and osteoporosis research with alendronate and leuprolide (coral) study European Urology, May 2, 2013

3 Obesity and prostate cancer: weighing the evidence European Urology, May 3, 2013    Review Article

4 The relationship between nutrition and prostate cancer: is more always better? European Urology, May 3, 2013    Review Article

5 Men with prostate cancer make positive dietary changes following diagnosis and treatment Cancer Causes and Control, May 7, 2013

6 Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity Cancer, May 1, 2013

7 Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy British Journal of Cancer, May 3, 2013

8 Caffeine intake and its association with urinary incontinence in United States men: results from national health and nutrition examination surveys 2005–2006 and 2007–2008 The Journal of Urology, May 13, 2013

9 A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer Investigational New Drugs, May 7, 2013

10 Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trials Journal of Clinical Oncology, May 1, 2013    Review Article